Russell Investments Group’s Inozyme Pharma INZY Stock Holding History

Russell Investments Group’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,035	Closed	-$4.14K	–	4186
2025 Q2	$4.14K	Buy	+1,035	New	+$2.56K	﹤0.01%	3488
2025 Q1	–	Sell	-3,478	Closed	-$9.63K	–	3835
2024 Q4	$9.63K	Buy	+3,478	New	+$13.2K	﹤0.01%	3142
2024 Q3	–	Sell	-433	Closed	-$1.93K	–	3742
2024 Q2	$1.93K	Buy	+433	New	+$2.1K	﹤0.01%	3352
2021 Q4	–	Sell	-115,516	Closed	-$1.34M	–	3050
2021 Q3	$1.34M	Buy	115,516 +113,015	+4,519%	+$1.76M	﹤0.01%	2058
2021 Q2	$42K	Buy	+2,501	New	+$43.5K	﹤0.01%	3145

Russell Investments Group's INZY Position: Q3 2025 in Review

Russell Investments Group sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 1,035 shares — an estimated $4.14K sold.

Russell Investments Group first reported a position in INZY in Q2 2021 and held it in 5 quarters. The position peaked at $1.34M in Q3 2021. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Russell Investments Group reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Russell Investments Group sold 1,035 Inozyme Pharma shares in Q3 2025, an estimated $4.14K.
Russell Investments Group first reported a position in Inozyme Pharma in Q2 2021 and held it in 5 quarters.
Russell Investments Group's Inozyme Pharma position peaked at $1.34M in Q3 2021.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.